

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.58549353 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.58549353 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.58549353 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.58549353 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.58549353 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.58549353 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.35806959 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.35806959 |
| 9 | response to peptidoglycan (GO:0032494) | 5.83989405 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.53512993 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.52958814 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.46403872 |
| 13 | detection of other organism (GO:0098543) | 5.34882966 |
| 14 | detection of bacterium (GO:0016045) | 5.12703797 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 5.05448803 |
| 16 | response to host immune response (GO:0052572) | 5.02195806 |
| 17 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.02195806 |
| 18 | respiratory burst (GO:0045730) | 4.96721381 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.96648593 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.86884007 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.78477676 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.57989856 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54661724 |
| 24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.53945827 |
| 25 | response to host (GO:0075136) | 4.53945827 |
| 26 | response to host defenses (GO:0052200) | 4.53945827 |
| 27 | microglial cell activation (GO:0001774) | 4.52590080 |
| 28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.46201752 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.19519802 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.19170853 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 4.18269885 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.15356072 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 4.12686395 |
| 34 | detection of biotic stimulus (GO:0009595) | 4.04343161 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.92928510 |
| 36 | macrophage activation (GO:0042116) | 3.91264396 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90957569 |
| 38 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.90057044 |
| 39 | granulocyte activation (GO:0036230) | 3.85260289 |
| 40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.85092577 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 3.84026463 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.83307293 |
| 43 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.78617793 |
| 44 | positive regulation of mast cell degranulation (GO:0043306) | 3.78617793 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.75912362 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.75091213 |
| 47 | neutrophil activation (GO:0042119) | 3.71750071 |
| 48 | regulation of mast cell degranulation (GO:0043304) | 3.71596990 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.61930970 |
| 50 | reactive oxygen species biosynthetic process (GO:1903409) | 3.61370840 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 3.60569784 |
| 52 | B cell mediated immunity (GO:0019724) | 3.59188029 |
| 53 | positive regulation of interferon-beta production (GO:0032728) | 3.58613447 |
| 54 | response to interleukin-15 (GO:0070672) | 3.58322054 |
| 55 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.57531496 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.56915962 |
| 57 | regulation of chemokine biosynthetic process (GO:0045073) | 3.55211434 |
| 58 | cellular extravasation (GO:0045123) | 3.53272759 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.52692699 |
| 60 | superoxide anion generation (GO:0042554) | 3.49313637 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 3.48592768 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47932954 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45377967 |
| 64 | regulation of T cell tolerance induction (GO:0002664) | 3.44381691 |
| 65 | regulation of mononuclear cell migration (GO:0071675) | 3.41281242 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38634398 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 3.38082532 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.36718235 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.34221849 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.33609872 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.33609872 |
| 72 | neutrophil mediated immunity (GO:0002446) | 3.32830778 |
| 73 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.32592975 |
| 74 | leukocyte aggregation (GO:0070486) | 3.30787086 |
| 75 | I-kappaB phosphorylation (GO:0007252) | 3.30640601 |
| 76 | response to type I interferon (GO:0034340) | 3.30179338 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28249646 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28099252 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.27756216 |
| 80 | leukocyte degranulation (GO:0043299) | 3.25787788 |
| 81 | cellular response to interleukin-15 (GO:0071350) | 3.25629344 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25473729 |
| 83 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23395059 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23395059 |
| 85 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.23298447 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 3.23278524 |
| 87 | positive regulation of leukocyte degranulation (GO:0043302) | 3.21817971 |
| 88 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21789796 |
| 89 | regulation of podosome assembly (GO:0071801) | 3.20909426 |
| 90 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19835945 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 3.18504758 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 3.18448974 |
| 93 | low-density lipoprotein particle clearance (GO:0034383) | 3.18330461 |
| 94 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.16688037 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16131440 |
| 96 | positive regulation of heat generation (GO:0031652) | 3.15555572 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14955897 |
| 98 | regulation of B cell differentiation (GO:0045577) | 3.14506849 |
| 99 | regulation of leukocyte degranulation (GO:0043300) | 3.13371678 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 3.12985102 |
| 101 | lymphocyte chemotaxis (GO:0048247) | 3.11922618 |
| 102 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.10402596 |
| 103 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07787702 |
| 104 | myeloid leukocyte mediated immunity (GO:0002444) | 3.07265523 |
| 105 | defense response to protozoan (GO:0042832) | 3.06936293 |
| 106 | regulation of cholesterol storage (GO:0010885) | 3.04877552 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04519467 |
| 108 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.04062848 |
| 109 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.02737628 |
| 110 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.02722312 |
| 111 | positive regulation of chemokine production (GO:0032722) | 3.01373796 |
| 112 | negative regulation of interleukin-6 production (GO:0032715) | 3.01089649 |
| 113 | neutrophil chemotaxis (GO:0030593) | 2.99463635 |
| 114 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98114534 |
| 115 | leukocyte mediated cytotoxicity (GO:0001909) | 2.97973149 |
| 116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97493035 |
| 117 | pinocytosis (GO:0006907) | 2.95115333 |
| 118 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94293084 |
| 119 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94293084 |
| 120 | negative regulation of mast cell activation (GO:0033004) | 2.92954541 |
| 121 | myeloid leukocyte activation (GO:0002274) | 2.92174954 |
| 122 | germinal center formation (GO:0002467) | 2.91894239 |
| 123 | negative regulation of innate immune response (GO:0045824) | 2.91212775 |
| 124 | neutrophil migration (GO:1990266) | 2.90851607 |
| 125 | regulation of fever generation (GO:0031620) | 2.88813689 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88246620 |
| 127 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88246620 |
| 128 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.88187316 |
| 129 | T-helper 1 type immune response (GO:0042088) | 2.88101710 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85032203 |
| 131 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.84377257 |
| 132 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.84328675 |
| 133 | myeloid dendritic cell differentiation (GO:0043011) | 2.84306442 |
| 134 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.80304794 |
| 135 | natural killer cell mediated immunity (GO:0002228) | 2.80304794 |
| 136 | negative regulation of growth of symbiont in host (GO:0044130) | 2.79277618 |
| 137 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.79277618 |
| 138 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.79277618 |
| 139 | regulation of growth of symbiont in host (GO:0044126) | 2.79277618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.20388034 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.44286255 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.12836081 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.74772485 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.35853970 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.88082539 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.76562783 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66907844 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.55252139 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45105635 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25051560 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.24855688 |
| 13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.78864332 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77481120 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72792733 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.72470673 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69297233 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.48118069 |
| 19 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41157553 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.30575291 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.27263123 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16988216 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.02186385 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00679747 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98943888 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97108155 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93647643 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93044096 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84108067 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80796502 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77601627 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.77112093 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75831036 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73755274 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72686336 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63527740 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63248408 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.61941386 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.61919267 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61842573 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55394138 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51604368 |
| 43 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50774764 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48638365 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48637109 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40945217 |
| 47 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40500087 |
| 48 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40176611 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39526703 |
| 50 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38182595 |
| 51 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38121556 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.31906280 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31764870 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31431992 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30032899 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29088536 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27378087 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24935923 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24741593 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22291140 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18144950 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17325187 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17089078 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15963923 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14108161 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13333093 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11558939 |
| 68 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11478797 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08389896 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05891019 |
| 71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03035757 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02003284 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01455421 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01393245 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99029426 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 0.98535845 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98267542 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95161124 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94778710 |
| 80 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94737092 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 0.94641925 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93186032 |
| 83 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92975550 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92881215 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92486628 |
| 86 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90672463 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89520196 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86449409 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85565842 |
| 90 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84623726 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83441154 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81625816 |
| 93 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81231449 |
| 94 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80911387 |
| 95 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80803461 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80401293 |
| 97 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79257356 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79083912 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79037712 |
| 100 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78558605 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77569234 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77532004 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73001252 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72298302 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72019167 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71240871 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69418187 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69060322 |
| 109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.66285997 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64594317 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.63018382 |
| 112 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.62381076 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.62304299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.19904692 |
| 2 | MP0003303_peritoneal_inflammation | 4.11214186 |
| 3 | MP0003436_decreased_susceptibility_to | 4.06000545 |
| 4 | MP0009785_altered_susceptibility_to | 3.60662757 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.53133946 |
| 6 | MP0002419_abnormal_innate_immunity | 3.37138955 |
| 7 | MP0006082_CNS_inflammation | 3.31407537 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.18734627 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.08572040 |
| 10 | MP0003724_increased_susceptibility_to | 2.96210624 |
| 11 | MP0005025_abnormal_response_to | 2.95463701 |
| 12 | MP0001790_abnormal_immune_system | 2.83253817 |
| 13 | MP0005387_immune_system_phenotype | 2.83253817 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.57426985 |
| 15 | MP0004510_myositis | 2.57129311 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.47854084 |
| 17 | MP0001800_abnormal_humoral_immune | 2.47279469 |
| 18 | MP0002723_abnormal_immune_serum | 2.38758389 |
| 19 | MP0000685_abnormal_immune_system | 2.36440865 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.35905353 |
| 21 | MP0009840_abnormal_foam_cell | 2.33162673 |
| 22 | MP0005671_abnormal_response_to | 2.32435692 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.29226476 |
| 24 | MP0001819_abnormal_immune_cell | 2.14110367 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.11130080 |
| 26 | MP0000343_altered_response_to | 2.06313722 |
| 27 | MP0004947_skin_inflammation | 1.95936952 |
| 28 | MP0009278_abnormal_bone_marrow | 1.95828813 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.93808724 |
| 30 | MP0002405_respiratory_system_inflammati | 1.91865702 |
| 31 | MP0003075_altered_response_to | 1.90613823 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.88857199 |
| 33 | MP0000604_amyloidosis | 1.85700501 |
| 34 | MP0008469_abnormal_protein_level | 1.80176207 |
| 35 | MP0009764_decreased_sensitivity_to | 1.75728654 |
| 36 | MP0001853_heart_inflammation | 1.74748831 |
| 37 | MP0002132_abnormal_respiratory_system | 1.72175913 |
| 38 | MP0003448_altered_tumor_morphology | 1.71746038 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.71259285 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.66437519 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.64465976 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.57476539 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.50141966 |
| 44 | MP0000716_abnormal_immune_system | 1.49026887 |
| 45 | MP0003690_abnormal_glial_cell | 1.44313821 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.42596479 |
| 47 | MP0004858_abnormal_nervous_system | 1.41084884 |
| 48 | MP0003866_abnormal_defecation | 1.39375541 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.37103300 |
| 50 | MP0005310_abnormal_salivary_gland | 1.36496797 |
| 51 | MP0005166_decreased_susceptibility_to | 1.35772784 |
| 52 | MP0002398_abnormal_bone_marrow | 1.35358707 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.31705751 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.31705751 |
| 55 | MP0002006_tumorigenesis | 1.29841172 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.27812019 |
| 57 | MP0000858_altered_metastatic_potential | 1.22126327 |
| 58 | MP0002429_abnormal_blood_cell | 1.20085123 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.18420839 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.17816001 |
| 61 | MP0004381_abnormal_hair_follicle | 1.16667432 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.11753716 |
| 63 | MP0001851_eye_inflammation | 1.11385006 |
| 64 | MP0010307_abnormal_tumor_latency | 1.10890695 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.09868635 |
| 66 | MP0002722_abnormal_immune_system | 1.09757486 |
| 67 | MP0005390_skeleton_phenotype | 1.07619234 |
| 68 | MP0005164_abnormal_response_to | 1.05556486 |
| 69 | MP0002933_joint_inflammation | 1.04963079 |
| 70 | MP0005083_abnormal_biliary_tract | 1.04833084 |
| 71 | MP0009763_increased_sensitivity_to | 1.03628497 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.03110912 |
| 73 | MP0003828_pulmonary_edema | 1.02513128 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.00923041 |
| 75 | MP0005257_abnormal_intraocular_pressure | 0.97193056 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.96193078 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.95113269 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.92882316 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.92722263 |
| 80 | MP0003186_abnormal_redox_activity | 0.92422625 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.92224552 |
| 82 | MP0008004_abnormal_stomach_pH | 0.89530336 |
| 83 | MP0000249_abnormal_blood_vessel | 0.83103668 |
| 84 | MP0008260_abnormal_autophagy | 0.81169592 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.78810160 |
| 86 | MP0003195_calcinosis | 0.75133867 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 0.73090499 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.72179565 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.71359346 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.70849124 |
| 91 | MP0005023_abnormal_wound_healing | 0.68491357 |
| 92 | MP0003795_abnormal_bone_structure | 0.68444850 |
| 93 | MP0000490_abnormal_crypts_of | 0.67737957 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.67236020 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.66433767 |
| 96 | MP0003045_fibrosis | 0.66139356 |
| 97 | MP0001958_emphysema | 0.64777474 |
| 98 | MP0008874_decreased_physiological_sensi | 0.64505921 |
| 99 | MP0000609_abnormal_liver_physiology | 0.64252889 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.62587991 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.62533427 |
| 102 | MP0004883_abnormal_blood_vessel | 0.62345543 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.61617330 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57392352 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.57253652 |
| 106 | MP0001873_stomach_inflammation | 0.56839192 |
| 107 | MP0000920_abnormal_myelination | 0.56777728 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.56560346 |
| 109 | MP0005451_abnormal_body_composition | 0.56480144 |
| 110 | MP0004130_abnormal_muscle_cell | 0.55895054 |
| 111 | MP0008873_increased_physiological_sensi | 0.55270760 |
| 112 | MP0001663_abnormal_digestive_system | 0.55188424 |
| 113 | MP0003091_abnormal_cell_migration | 0.54014639 |
| 114 | MP0002090_abnormal_vision | 0.52601876 |
| 115 | MP0000371_diluted_coat_color | 0.52485148 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.52408940 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.51198147 |
| 118 | MP0003329_amyloid_beta_deposits | 0.49647934 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.47460381 |
| 120 | MP0002133_abnormal_respiratory_system | 0.47103069 |
| 121 | MP0005388_respiratory_system_phenotype | 0.47103069 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46976335 |
| 123 | MP0003878_abnormal_ear_physiology | 0.46149076 |
| 124 | MP0005377_hearing/vestibular/ear_phenot | 0.46149076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.59397699 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.72852292 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.59737959 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.26111659 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.87990444 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.44681938 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.30243197 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.89230349 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.86813462 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.60593652 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.23649701 |
| 12 | Myositis (HP:0100614) | 4.22843004 |
| 13 | Glomerulonephritis (HP:0000099) | 4.10161728 |
| 14 | Orchitis (HP:0100796) | 4.09300835 |
| 15 | Gingivitis (HP:0000230) | 4.06449930 |
| 16 | Stomatitis (HP:0010280) | 4.06272979 |
| 17 | Obstructive lung disease (HP:0006536) | 4.03774118 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.03774118 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.98972426 |
| 20 | Recurrent skin infections (HP:0001581) | 3.94778226 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.88124849 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.76344173 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.76344173 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.76344173 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.75660335 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.70996115 |
| 27 | Encephalitis (HP:0002383) | 3.64554055 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.62219523 |
| 29 | Optic neuritis (HP:0100653) | 3.62219523 |
| 30 | Axonal loss (HP:0003447) | 3.58643920 |
| 31 | Disinhibition (HP:0000734) | 3.44871426 |
| 32 | Hypochromic microcytic anemia (HP:0004840) | 3.41650010 |
| 33 | Increased IgE level (HP:0003212) | 3.31017622 |
| 34 | Recurrent fungal infections (HP:0002841) | 3.25978864 |
| 35 | Prolonged bleeding time (HP:0003010) | 3.24214319 |
| 36 | Pustule (HP:0200039) | 3.20895272 |
| 37 | Urticaria (HP:0001025) | 3.17263988 |
| 38 | Episodic fever (HP:0001954) | 3.16163766 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.15695096 |
| 40 | Vasculitis (HP:0002633) | 3.11263040 |
| 41 | Loss of speech (HP:0002371) | 3.09479007 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08782489 |
| 43 | Mucopolysacchariduria (HP:0008155) | 3.08782489 |
| 44 | Chest pain (HP:0100749) | 3.08734528 |
| 45 | Abnormality of complement system (HP:0005339) | 3.05843014 |
| 46 | Hypochromic anemia (HP:0001931) | 2.99668941 |
| 47 | Prostate neoplasm (HP:0100787) | 2.96147603 |
| 48 | Cellulitis (HP:0100658) | 2.95366126 |
| 49 | Thick nail (HP:0001805) | 2.94754824 |
| 50 | Periodontitis (HP:0000704) | 2.88969623 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.88810947 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.88810947 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.88810947 |
| 54 | Recurrent viral infections (HP:0004429) | 2.87564148 |
| 55 | Complement deficiency (HP:0004431) | 2.84378170 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.74435991 |
| 57 | Nephritis (HP:0000123) | 2.73404644 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.72474709 |
| 59 | T lymphocytopenia (HP:0005403) | 2.71488354 |
| 60 | Epistaxis (HP:0000421) | 2.70021341 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.68947687 |
| 62 | Pulmonary embolism (HP:0002204) | 2.68271896 |
| 63 | Chronic otitis media (HP:0000389) | 2.65041382 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.64893409 |
| 65 | Meningitis (HP:0001287) | 2.61585234 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.60722501 |
| 67 | Purpura (HP:0000979) | 2.60400865 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.59977200 |
| 69 | Myocardial infarction (HP:0001658) | 2.59481181 |
| 70 | Hematochezia (HP:0002573) | 2.57475501 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.56628082 |
| 72 | Agnosia (HP:0010524) | 2.55206867 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.53984761 |
| 74 | Panhypogammaglobulinemia (HP:0003139) | 2.40057782 |
| 75 | Osteomyelitis (HP:0002754) | 2.35720559 |
| 76 | Tetraparesis (HP:0002273) | 2.34701511 |
| 77 | Abnormality of T cells (HP:0002843) | 2.34250061 |
| 78 | Leukocytosis (HP:0001974) | 2.32809071 |
| 79 | Increased IgM level (HP:0003496) | 2.31048469 |
| 80 | Arterial thrombosis (HP:0004420) | 2.30302116 |
| 81 | Recurrent pneumonia (HP:0006532) | 2.29595439 |
| 82 | Gangrene (HP:0100758) | 2.28534106 |
| 83 | Microcytic anemia (HP:0001935) | 2.26572670 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.24924263 |
| 85 | Amyloidosis (HP:0011034) | 2.24714385 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.23809757 |
| 87 | Sepsis (HP:0100806) | 2.23568979 |
| 88 | Joint hemorrhage (HP:0005261) | 2.21777684 |
| 89 | Granulocytopenia (HP:0001913) | 2.21670719 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.20292375 |
| 91 | Gingival bleeding (HP:0000225) | 2.18235951 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.17153907 |
| 93 | Lymphopenia (HP:0001888) | 2.16935355 |
| 94 | Petechiae (HP:0000967) | 2.16766779 |
| 95 | Pathologic fracture (HP:0002756) | 2.13728941 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13155459 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 2.13155459 |
| 98 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11390631 |
| 99 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11390631 |
| 100 | Vertigo (HP:0002321) | 2.09641420 |
| 101 | Glomerulopathy (HP:0100820) | 2.08696065 |
| 102 | Poor head control (HP:0002421) | 2.06701849 |
| 103 | Abnormality of the endocardium (HP:0004306) | 2.06462536 |
| 104 | Polyneuropathy (HP:0001271) | 2.05184072 |
| 105 | Hemoptysis (HP:0002105) | 2.04824421 |
| 106 | Premature loss of primary teeth (HP:0006323) | 2.04577719 |
| 107 | Peritonitis (HP:0002586) | 2.03835908 |
| 108 | Acne (HP:0001061) | 2.03025689 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 2.01922673 |
| 110 | Abnormality of the prostate (HP:0008775) | 2.01191115 |
| 111 | Nasal polyposis (HP:0100582) | 2.00461973 |
| 112 | Colitis (HP:0002583) | 2.00457467 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 2.00218640 |
| 114 | Keratoconjunctivitis (HP:0001096) | 2.00073723 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99971141 |
| 116 | Anorexia (HP:0002039) | 1.99927631 |
| 117 | Bone pain (HP:0002653) | 1.99099840 |
| 118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98754840 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.98077155 |
| 120 | Esophageal neoplasm (HP:0100751) | 1.96751064 |
| 121 | Neoplasm of head and neck (HP:0012288) | 1.96751064 |
| 122 | Abnormality of the nasal mucosa (HP:0000433) | 1.95765861 |
| 123 | Inflammation of the large intestine (HP:0002037) | 1.95475524 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.94944802 |
| 125 | Progressive visual loss (HP:0000529) | 1.94941135 |
| 126 | Diminished motivation (HP:0000745) | 1.94586238 |
| 127 | Keratitis (HP:0000491) | 1.93591403 |
| 128 | Abnormality of the lumbar spine (HP:0100712) | 1.93300904 |
| 129 | Skin ulcer (HP:0200042) | 1.92764318 |
| 130 | Increased serum ferritin (HP:0003281) | 1.91757299 |
| 131 | Nausea (HP:0002018) | 1.91286532 |
| 132 | Thoracic kyphosis (HP:0002942) | 1.90840475 |
| 133 | Apathy (HP:0000741) | 1.89691235 |
| 134 | Abnormal platelet volume (HP:0011876) | 1.89100836 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.86140094 |
| 136 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84089240 |
| 137 | Mutism (HP:0002300) | 1.80402420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.01564054 |
| 2 | RIPK4 | 3.75379463 |
| 3 | TBK1 | 3.71171557 |
| 4 | MAP3K14 | 3.62417814 |
| 5 | IRAK4 | 3.42984442 |
| 6 | TYK2 | 3.38710345 |
| 7 | IRAK3 | 3.22254507 |
| 8 | ERN1 | 3.17543375 |
| 9 | MAP4K1 | 3.09135290 |
| 10 | KIT | 2.58499507 |
| 11 | IKBKE | 2.54352644 |
| 12 | TNK2 | 2.48998851 |
| 13 | CSK | 2.12977924 |
| 14 | IKBKB | 2.10354104 |
| 15 | PRPF4B | 2.02144887 |
| 16 | TAOK1 | 1.96559464 |
| 17 | TXK | 1.92603712 |
| 18 | FGR | 1.90024908 |
| 19 | CSF1R | 1.83645513 |
| 20 | FES | 1.82972117 |
| 21 | JAK1 | 1.80038304 |
| 22 | JAK3 | 1.71145622 |
| 23 | TGFBR2 | 1.66770129 |
| 24 | HCK | 1.65377400 |
| 25 | EPHB1 | 1.62155173 |
| 26 | ZAP70 | 1.53226977 |
| 27 | SYK | 1.50468168 |
| 28 | PBK | 1.45793321 |
| 29 | BTK | 1.38413930 |
| 30 | MAP3K13 | 1.36856371 |
| 31 | LYN | 1.35887339 |
| 32 | TRIB3 | 1.35550102 |
| 33 | PIM2 | 1.28637085 |
| 34 | MATK | 1.27687720 |
| 35 | NEK9 | 1.26708627 |
| 36 | TAOK3 | 1.24937666 |
| 37 | JAK2 | 1.22915425 |
| 38 | STK10 | 1.12051617 |
| 39 | RIPK1 | 1.12009696 |
| 40 | RPS6KA4 | 1.10168461 |
| 41 | LCK | 1.08552990 |
| 42 | PKN2 | 1.07031167 |
| 43 | NME2 | 1.07019234 |
| 44 | CHUK | 1.06744267 |
| 45 | MAP2K3 | 1.06418542 |
| 46 | TEC | 0.98981104 |
| 47 | CAMK1D | 0.98375744 |
| 48 | MARK2 | 0.97082143 |
| 49 | ABL2 | 0.95495110 |
| 50 | BMX | 0.95122915 |
| 51 | GRK7 | 0.94295345 |
| 52 | PRKD2 | 0.93747725 |
| 53 | CLK1 | 0.88555300 |
| 54 | IRAK1 | 0.88468138 |
| 55 | MARK3 | 0.85280849 |
| 56 | CDK19 | 0.82884503 |
| 57 | IRAK2 | 0.80374136 |
| 58 | MAP3K11 | 0.80260360 |
| 59 | TESK2 | 0.79131502 |
| 60 | PRKCD | 0.76569857 |
| 61 | PIM1 | 0.75974843 |
| 62 | PTK6 | 0.74827857 |
| 63 | EGFR | 0.74715602 |
| 64 | LRRK2 | 0.72236764 |
| 65 | MAPK12 | 0.70884414 |
| 66 | ABL1 | 0.69708297 |
| 67 | MAP3K6 | 0.66787100 |
| 68 | PAK4 | 0.66299978 |
| 69 | SIK2 | 0.66018693 |
| 70 | MAP2K4 | 0.65955170 |
| 71 | TTN | 0.65415118 |
| 72 | CDC42BPA | 0.64836989 |
| 73 | MAP3K10 | 0.64166074 |
| 74 | ITK | 0.63970636 |
| 75 | MAP3K7 | 0.62263128 |
| 76 | MST1R | 0.62166351 |
| 77 | FGFR4 | 0.60981457 |
| 78 | MAP3K3 | 0.59641413 |
| 79 | MAPK7 | 0.59231429 |
| 80 | PTK2B | 0.58960027 |
| 81 | STK11 | 0.56666302 |
| 82 | DYRK1B | 0.55464299 |
| 83 | GRK6 | 0.55078600 |
| 84 | MAP3K2 | 0.54457416 |
| 85 | BMPR2 | 0.53790969 |
| 86 | RPS6KA6 | 0.52887785 |
| 87 | FGFR3 | 0.50837951 |
| 88 | DAPK2 | 0.50520617 |
| 89 | KSR2 | 0.50161140 |
| 90 | SGK3 | 0.49680006 |
| 91 | CAMK1G | 0.49592109 |
| 92 | MAP3K5 | 0.48355528 |
| 93 | TAOK2 | 0.47828527 |
| 94 | FYN | 0.47176695 |
| 95 | TRPM7 | 0.46925803 |
| 96 | EIF2AK2 | 0.46654023 |
| 97 | PRKG2 | 0.44713925 |
| 98 | MAP3K1 | 0.44237920 |
| 99 | MAP2K6 | 0.43962181 |
| 100 | EPHA3 | 0.43185134 |
| 101 | KSR1 | 0.42643509 |
| 102 | ALK | 0.42024563 |
| 103 | MOS | 0.41624462 |
| 104 | CAMKK2 | 0.41512294 |
| 105 | CAMKK1 | 0.40800000 |
| 106 | KDR | 0.40789162 |
| 107 | RPS6KC1 | 0.40146990 |
| 108 | RPS6KL1 | 0.40146990 |
| 109 | HIPK2 | 0.38588671 |
| 110 | YES1 | 0.37489311 |
| 111 | STK4 | 0.37342759 |
| 112 | MAPKAPK2 | 0.36973526 |
| 113 | ARAF | 0.36675829 |
| 114 | PDPK1 | 0.36523685 |
| 115 | ADRBK2 | 0.35133068 |
| 116 | RAF1 | 0.35113161 |
| 117 | TESK1 | 0.34974022 |
| 118 | PDK1 | 0.34599198 |
| 119 | SMG1 | 0.34465714 |
| 120 | RET | 0.33126080 |
| 121 | DAPK3 | 0.32983442 |
| 122 | SIK1 | 0.32742606 |
| 123 | SIK3 | 0.31751281 |
| 124 | STK38 | 0.30871883 |
| 125 | SCYL2 | 0.30616276 |
| 126 | PRKCZ | 0.30400898 |
| 127 | MAPK4 | 0.30352637 |
| 128 | PIK3CG | 0.30312170 |
| 129 | PRKCQ | 0.29536658 |
| 130 | SGK2 | 0.29427604 |
| 131 | IGF1R | 0.27222853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.36276366 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.72527798 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.88322042 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63256902 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.61944041 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.53168042 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.48252122 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.38246722 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.34980276 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.34294781 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31257488 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20628910 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06640250 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03708649 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.99491644 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92272701 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89868956 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88266910 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.86125411 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.84539101 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84055582 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84054766 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.82766750 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.80939165 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77231611 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.74255776 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.72021764 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60100476 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59244978 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52068183 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.45176462 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44074028 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.42427893 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42400758 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39244361 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37833478 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32441464 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29253915 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.27451471 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19780651 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13623073 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12223366 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10730164 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10420174 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09770840 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.08108524 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04364795 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04091846 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.03648596 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 1.01846324 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99129910 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.92081954 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87430718 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84513761 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84248013 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82494717 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80962850 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77641552 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77149818 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71329013 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69323231 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67282725 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66845042 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.65886098 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64511979 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62449423 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60499629 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56182320 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55054236 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54148510 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53316694 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52865796 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52212144 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51083043 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49471550 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.49411831 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47550304 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45820013 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44371768 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44260484 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43946284 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43413128 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42827473 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42376753 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41922408 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40616177 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40586688 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.40198283 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39777236 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38802823 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38658560 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37802999 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36550527 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35476990 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35083554 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.33349187 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33229546 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30525823 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26389599 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25202536 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24948782 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24857481 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24419612 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24339451 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22177869 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20754803 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18530511 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14455275 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14430398 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.14170295 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12694709 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.09386083 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.08231608 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08021959 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.06874636 |

